Arcturus Therapeutics Holdings (ARCT) Non-Current Debt (2018 - 2025)

Arcturus Therapeutics Holdings has reported Non-Current Debt for 7 years, with the latest figure at $15.0 million in Q1 2025.

• For the quarter ending Q1 2025, Non-Current Debt changed N/A year-over-year to $15.0 million; the trailing twelve-month figure through Mar 2025 stood at $15.0 million (changed N/A YoY), and the FY2021 full-year result was $40.6 million, up 193.49% from the prior year.
• Non-Current Debt for Q1 2025 stood at $15.0 million, down from $20.0 million in the prior quarter.
• The five-year high for Non-Current Debt was $58.1 million in Q1 2021, with the low at $15.0 million in Q1 2025.
• Historically, Non-Current Debt has averaged $37.7 million across 4 years, with a median of $39.2 million in 2022.
• Annual changes were most pronounced in 2021 — Non-Current Debt soared 286.92% — and 2023, when it plunged 37.57%.
• Arcturus Therapeutics Holdings' Non-Current Debt stood at $40.6 million in 2021, then slipped by 21.15% to $32.0 million in 2022, then sank by 37.57% to $20.0 million in 2023, then retreated by 25.0% to $15.0 million in 2025.
• The last three Non-Current Debt figures came in at $15.0 million (Q1 2025), $20.0 million (Q3 2023), and $32.0 million (Q3 2022), per Business Quant data.